Screener Summaries Updates Institutions Sign In More Updates › Dividends & Buybacks › INCR Dividends & Buybacks · Jul 22, 2026
InterCure Ltd. has announced an Extraordinary General Meeting of Shareholders on August 12, 2026, to vote on a… INCR Intercure Ltd.
InterCure Ltd. has announced an Extraordinary General Meeting of Shareholders on August 12, 2026, to vote on a proposed 5-to-1 reverse share split. The company aims to maintain its Nasdaq Global Market listing by increasing its share price above the minimum $1.00 requirement. InterCure Ltd. operates in the medical cannabis industry.
More from Intercure Ltd. InterCure Ltd. regained compliance with Nasdaq's minimum bid price requirement following a delisting notice received… Sep 8, 2026 On August 12, 2026, InterCure Ltd. entered into a securities purchase agreement for a private placement offering of… Aug 26, 2026 InterCure finalized a settlement with Israeli authorities for NIS 230 million (approximately US$77 million) in… Aug 24, 2026 InterCure Ltd. has called an Extraordinary General Meeting of Shareholders for August 11, 2026, to vote on a proposed… Jul 27, 2026 On June 22, 2026, InterCure Ltd. entered into a binding term sheet for a private placement securing approximately NIS… Jun 22, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
